[Antagonists of neuromuscular blockade--mechanisms of action, adverse effects and dosages].
D000818:Animals; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D002802:Cholinesterases / Q000502:physiology; D004347:Drug Interactions; D005861:Germine Acetates / Q000494:pharmacology; D006801:Humans; D009045:Motor Endplate / Q000378:metabolism; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000378:metabolism; D013390:Succinylcholine / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D005861:Germine Acetates; D009466:Neuromuscular Blocking Agents; D003473:Neuromuscular Nondepolarizing Agents; D018377:Neurotransmitter Agents; D002802:Cholinesterases; D013390:Succinylcholine
Antagonisten der neuromuskulären Blockade - Wirkungsmechnismus, Nebenwirkungen und Dosierungen.